- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06754202
Silver Agri Age: Longevity, Intrinsic Capacity and Cognitive Impairment Into Farmlands and Natural Environments: Updating Contexts Following the "Montessori" Action (Silver Agri Ag)
This project aims to enhance the intrinsic capacities of elderly individuals with mild cognitive impairment by promoting innovative activities based on the Montessori approach within the context of agricultural multifunctionality.
By selecting a rural environment with educational characteristics, we aim to involve individuals with mild cognitive deficits and their families in a personalized therapeutic journey. Through various activities, including horticulture, pet therapy, occupational therapies, sensory and food laboratories, we stimulate cognitive and motor skills, promoting a healthy and balanced lifestyle
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Promoting innovative activities following the "Montessori" action in the context of the agricultural multifunctionality, in order to leverage the intrinsic capacity in older people with cognitive impairment.
- Identifying a rural environment with educational features.
- Identifying individuals with mild cognitive impairments and relations with their families.
- Outlining individual therapeutic goals for each participant through different activities:
horticulture, pet therapy, occupational therapies, sensory laboratories, functional food laboratories for a healthy and balanced diet suitable for the first symptoms of dementia, physical activity and continuous social activity between different generations.
- Horticulture, pet therapy, occupational therapy, sensory labs, physical activity, and social activities IN CONTINUITY between different generations.
- Spreading the results to a wide National and International audience.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Anna Rita Bonfigli, PhD
- Phone Number: 00390718003719
- Email: a.bonfigli@inrca.it
Study Locations
-
-
-
Ancona, Italy, 60127
- Recruiting
- INRCA Hospital
-
Contact:
- Anna Rita Bonfigli
- Phone Number: 0718003719
-
Principal Investigator:
- Cristina Gagliardi, MsC
-
Fermo, Italy, 63900
- Recruiting
- INRCA Hospital
-
Contact:
- Anna Rita Bonfigli
- Phone Number: 0718003719
-
Principal Investigator:
- Cinzia Giuli, Psych
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- diagnosis of mild cognitive impairment (MCI);
- Mini Mental State Examination ≥ 24;
- ability and willingness to sign informed consent
Exclusion Criteria:
- Mini Mental State Examination < 24;
- severe visual impairment;
- inability to walk without help or assistance, Tinetti's scale <20
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Subjects with mild cognitive impairment (MCI)
Subjects with mild cognitive oimpairment (MCI) and self-sufficient in mobility that agreed to partecipate in various activities in rural enviroment.
|
The nine-month program will include social activities following the "Montessori" action in the context of the agricultural multifunctionality such as horticulture, pet therapy, occupational therapy, sensory labs, physical activity held three days a week for five hours each day.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in the positive and negative affects
Time Frame: At baseline and after 9 months
|
The PANAS (Positive and Negative Affect Schedule) produces two distinct dimensions of affect: Positive Affect (PA): Measures emotions like joy, interest, excitement, and enthusiasm and Negative Affect (NA): Measures emotions like fear, anger, sadness, and guilt. Participants rate each of the 20 items (10 for PA, 10 for NA) on a 5-point scale (from 1 = "Very slightly or not at all" to 5 = "Extremely"). The possible score range for both PA and NA is 10 to 50. Higher scores indicate higher levels of that particular affect Scores for each subscale are calculated by summing the ratings for the corresponding items. |
At baseline and after 9 months
|
Collaborators and Investigators
Collaborators
Investigators
- Study Chair: Cristina Gagliardi, MsC, Irccs Inrca
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- INRCA_005_2024
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment (MCI)
-
University of FloridaRecruitingMild Cognitive Impairment (MCI) | Mild Cognitive Impairment | MCIUnited States
-
High Point UniversityWake Forest University Health Sciences; Hebrew SeniorLifeRecruitingMild Cognitive Impairment (MCI)United States
-
Azienda Ospedaliera SS. Antonio e Biagio e Cesare...Dr. Schär AG / SPARecruitingMild Cognitive Impairment (MCI)Italy
-
Immunotec Inc.RecruitingMild Cognitive Impairment (MCI)Canada
-
Çankırı Karatekin UniversityCompletedMild Cognitive Impairment (MCI)Turkey (Türkiye)
-
University of AlbertaCompleted
-
Friedhelm HummelThe Novartis Foundation; Wyss Center for Bio and Neuroengineering; Clinique Romande... and other collaboratorsCompletedMild Cognitive Impairment (MCI)Switzerland
-
Meir Medical CenterTerminatedMild Cognitive Impairment (MCI)Israel
-
Singapore General HospitalSingapore Health ServicesNot yet recruitingMild Cognitive Impairment (MCI) | Mild Cognitive Impairment
-
Xuanwu Hospital, BeijingNot yet recruitingMild Cognitive Impairment (MCI)China
Clinical Trials on Social activities with cognitive stimulation
-
Hospices Civils de LyonUnknown
-
University of Geneva, SwitzerlandNot yet recruitingCognition | Ageing | Well-Being, PsychologicalSwitzerland
-
University of CyprusActive, not recruitingTraumatic Brain Injury | CVA (Cerebrovascular Accident)Cyprus
-
Universidad de ZaragozaRecruitingMild Cognitive Impairment | Randomized Controlled Trial | Subjective Cognitive ImpairmentSpain
-
VA Office of Research and DevelopmentCompleted
-
Vanderbilt UniversityNational Institute of Mental Health (NIMH)RecruitingDepressionUnited States
-
Universidad de los Andes, ChileUniversity of TalcaRecruitingBehavioral Problem of ChildChile
-
Vanderbilt UniversityNational Institute of Mental Health (NIMH)Completed
-
National University of Ireland, Galway, IrelandCompletedDementia | Dementia, Mild | Dementia ModerateIreland
-
University of BarcelonaMinisterio de Economía y Competitividad, SpainCompleted